Alex Rider, MD
Ophthalmology · Charleston, SCNPI 1932660958
Payments from drug & device makers
Across 59 payments — averaging $67.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$936
- Johnson & Johnson Surgical Vision, Inc.$658
- Harrow Eye, LLC$293
- Genentech USA, Inc.$250
- Ocular Therapeutix, Inc.$176
- Biotissue Holdings Inc.$167
- plus $2K from 14 others
What the payments were for
- Food & beverage$4,007100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 16 | $936 |
| Johnson & Johnson Surgical Vision, Inc. | 8 | $658 |
| Harrow Eye, LLC | 2 | $293 |
| Genentech USA, Inc. | 2 | $250 |
| Ocular Therapeutix, Inc. | 7 | $176 |
| Biotissue Holdings Inc. | 6 | $167 |
| Sun Pharmaceutical Industries Inc. | 1 | $140 |
| Genentech, Inc. | 1 | $137 |
| NEW World Medical,inc. | 1 | $131 |
| Axogen | 1 | $121 |
| Rxsight Inc | 1 | $120 |
| Glaukos Corporation | 2 | $114 |
| Johnson & Johnson Vision Care, Inc. | 1 | $111 |
| Regeneron Healthcare Solutions, Inc. | 1 | $110 |
| Amgen | 1 | $109 |
| Oyster Point Pharma, Inc. | 1 | $99 |
| Astellas Pharma US Inc | 1 | $99 |
| AbbVie | 2 | $99 |
| Dompe US, Inc. | 3 | $90 |
| Sight Sciences, Inc. | 1 | $48 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tecnis IOL$524
- VABYSMO$387
- Clareon$385
- VEVYE$171
- VERITAS Vision System$157
- CEQUA$140
- AMO PHACO NEEDLE$131
- ARGOS$129
- Hydrus Microstent$123
- Flarex$122
- IHEEZO$122
- Verkazia$122
- Tobradex ST$122
- Natacyn$122
- AVANCE NERVE GRAFT$121
- RXSIGHT CONTACT LENS$120
- RXSIGHT INJECTOR CARTRIDGE$120
- RXSIGHT INJECTOR HANDPIECE$120
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$120
- LIGHT ADJUSTABLE LENS (LAL)$120
How this compares
$4,007 in reported general payments places this provider in the 65th percentile of 293 ophthalmology providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 19 | $12,898 |
| Prednisolone Acetate | 47 | $1,612 |
| MoxifloxacinMoxifloxacin Hcl | 24 | $552 |
| Tobramycin | 12 | $479 |
| Ketorolac Tromethamine | 14 | $387 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Charleston
- Daniel AlfaroCharleston$4.6M
- Eric JablonCharleston$1.2M
- John KerrisonCharleston$975K
- Karolinne RochaCharleston$799K
- Mona CamacciCharleston$534K
- Marion WilsonCharleston$86K
- Drew DicksonCharleston$53K
- Michael JohnsonCharleston$23K
- Karen FernandezCharleston$22K
- Cole MillikenCharleston$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.